Emerald Bioscience Stock Beta
Emerald Bioscience fundamentals help investors to digest information that contributes to Emerald Bioscience's financial success or failures. It also enables traders to predict the movement of Emerald OTC Stock. The fundamental analysis module provides a way to measure Emerald Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emerald Bioscience otc stock.
Emerald |
Emerald Bioscience OTC Stock Beta Analysis
Emerald Bioscience's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Emerald Bioscience Beta | -0.04 |
Most of Emerald Bioscience's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emerald Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Emerald Bioscience has a Beta of -0.04. This is 104.65% lower than that of the Healthcare sector and 102.88% lower than that of the Biotechnology industry. The beta for all United States stocks is 73.33% lower than that of the firm.
Emerald Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emerald Bioscience's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emerald Bioscience could also be used in its relative valuation, which is a method of valuing Emerald Bioscience by comparing valuation metrics of similar companies.Emerald Bioscience is currently under evaluation in beta category among related companies.
As returns on the market increase, returns on owning Emerald Bioscience are expected to decrease at a much lower rate. During the bear market, Emerald Bioscience is likely to outperform the market.
Emerald Fundamentals
| Return On Equity | -740.91 | |||
| Return On Asset | -224.1 | |||
| Current Valuation | 86.55 M | |||
| Shares Outstanding | 133.91 M | |||
| Shares Owned By Insiders | 59.50 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (0.62) X | |||
| Price To Book | (9.09) X | |||
| Revenue | 399.91 K | |||
| Gross Profit | 166.22 K | |||
| EBITDA | (4.51 M) | |||
| Net Income | (19.19 M) | |||
| Cash And Equivalents | 1.85 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.36 M | |||
| Debt To Equity | (2.11) % | |||
| Current Ratio | 0.12 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (3.94 M) | |||
| Earnings Per Share | (0.16) X | |||
| Beta | -0.04 | |||
| Market Capitalization | 87.04 M | |||
| Total Asset | 692 K | |||
| Retained Earnings | (9.84 M) | |||
| Working Capital | (206 K) | |||
| Current Asset | 635 K | |||
| Current Liabilities | 841 K | |||
| Z Score | -1.0 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emerald Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emerald Bioscience's short interest history, or implied volatility extrapolated from Emerald Bioscience options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Bioscience's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |